# A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity

> **NCT07437079** · PHASE1 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 96 (estimated)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** NNC6989-0001 A
- **DRUG:** Placebo (NNC6989-0001 A)

## Key facts

- **NCT ID:** NCT07437079
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-24
- **Primary completion:** 2027-01-21
- **Final completion:** 2027-01-21
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07437079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07437079, "A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT07437079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*